Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection
{{output}}
Background: Severe pediatric asthma is a heterogeneous, high-burden disease marked by variable corticosteroid responsiveness, frequent exacerbations, and substantial impairment in quality of life. Advances in airway immunobiology... ...
